International Biotechnology Trust (IBT)
Category Sector Equity Biotechnology
This investment trust can be held in an Investment ISA, SIPP and Investment Account
Sell
686.00p
Buy
690.00p
8.00p (+1.18%)
Discount/Premium
-13.35%
Estimated NAV
791.703p
Prices updated at 22 Nov 2024, 00:00
| Prices minimum 15 mins delay
Prices in GBX
Investment objective
The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies. The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with suitably experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology.
Important documents: Please ensure that you have read the Key Information Document/Technical Guide
, Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.
- Key stats
- Price
- Performance
- Charges & documents
- Shares & trades
- Dividends
- Portfolio
- Risk
- News & dates
- Trust info
- Director info
Most recent dividend payment
| 0.145 | |
| Cash Dividend | |
| 25 Jul 2024 | |
| 03 Jul 2024 | |
| 26 Jul 2024 | |
| 23 Aug 2024 | |
| Dividend cover | - |
Income only yield
No data available
Dividend per share
Income only yield data table
| Year | Income only yield |
|---|---|
| 2024 | - |
| 2023 | - |
| 2022 | - |
| 2021 | - |
| 2020 | - |
| 2019 | - |
| 2018 | - |
| 2017 | - |
Dividend per share data table
| Year | Dividend per share |
|---|---|
| 2024 | 0.1450 |
| 2023 | 0.2810 |
| 2022 | 0.2970 |
| 2021 | 0.2990 |
| 2020 | 0.2660 |
| 2019 | 0.2640 |
| 2018 | 0.4100 |
| 2017 | 0.2300 |
